OSTEOGENEX INC has a total of 16 patent applications. Its first patent ever was published in 2007. It filed its patents most often in United States, Canada and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, medical technology and biotechnology are EUROGENE LTD, MONROE STEPHEN H and NUVO RES AG.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 9 | |
#2 | Canada | 2 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | WIPO (World Intellectual Property Organization) | 2 | |
#5 | Japan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology | |
#3 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Object sterilising | |
#4 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Ellies Debra | 14 |
#2 | Rosenberg William | 13 |
#3 | Ellies Debra L | 2 |
#4 | Kimball Ferris Scott | 1 |
Publication | Filing date | Title |
---|---|---|
US2014023653A1 | Boldine derivatives for promoting bone growth | |
US2010173931A1 | Harmine derivatives for reducing body weight | |
US2010143441A1 | Nortriptyline compounds for promoting bone growth | |
US2010074939A1 | Harmine compounds for promoting bone growth | |
US2010047314A1 | Folinic acid derivatives for promoting bone growth | |
CA2728301A1 | Vinpocetine and eburnamonine derivatives for promoting bone growth | |
US2009258052A1 | Compounds and methods for altering bone growth |